The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
 
Jean Emmanuel Kurtz
Employment - Merck Sharp & Dohme (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Eisai; GlaxoSmithKline
Travel, Accommodations, Expenses - Clovis Oncology; Eisai; GlaxoSmithKline
 
Amélie Anota
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Sandoz
Travel, Accommodations, Expenses - AstraZeneca
 
Claire Cropet
No Relationships to Disclose
 
Frank Priou
Consulting or Advisory Role - AstraZeneca
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Isabel Palacio
Consulting or Advisory Role - AstraZeneca Spain; Clovis Oncology; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; MSD Oncology; Roche
 
Edgar Petru
Honoraria - AGEA; Amgen; Amgen (Inst); Angelini Pharma; Angelini Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Eisai; GlaxoSmithKline; GlaxoSmithKline (Inst); Lilly; Lilly (Inst); MSD; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); PharmaMar; PharmaMar (Inst); Roche; Seagen
Consulting or Advisory Role - Amgen; Angelini Pharma; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; PharmaMar; Roche; Seagen
Travel, Accommodations, Expenses - AGEA; Amgen; AstraZeneca; GlaxoSmithKline; Pfizer; PharmaMar
 
Hiroaki Kobayashi
No Relationships to Disclose
 
Peter Vuylsteke
Honoraria - Novartis; Roche/Genentech
 
Gabriella Parma
No Relationships to Disclose
 
Johanna Mäenpää
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline (Inst)
 
Eric Raymond
No Relationships to Disclose
 
Paul Buderath
Honoraria - AstraZeneca/Daiichi Sankyo; Roche
Consulting or Advisory Role - Roche
 
Domenica Lorusso
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Genmab; GlaxoSmithKline; Immunogen; Merck Serono; MSD; Oncoinvest; PharmaMar; Seagen; Sutro Biopharma
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; GlaxoSmithKline; PharmaMar; Roche
(OPTIONAL) Uncompensated Relationships - Gynecological Cancer InterGroup
 
Ana Herrero
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Research Funding - AstraZeneca
 
Nadia Raban
No Relationships to Disclose
 
Eric Pujade-Lauraine
Employment - Arcagy-Gineco
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Incyte; Merck; Roche
Research Funding - AstraZeneca (Inst)
Other Relationship - Arcagy-Gineco
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; GlaxoSmithKline; Ipsen; Janssen
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; BMS; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Roche; Seagen; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES